Nuveen’s Elevance Health ELV Stock Holding History

Nuveen’s Portfolio ELV Stock Details ELV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-16,400	Closed	-$5K	–	3215
2019 Q4	$5K	Buy	+16,400	New	+$4.51M	﹤0.01%	3190

Other funds holding ELV

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Sanders Capital West Palm Beach, Florida $83.9B AUM 37.89% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Harris Associates Chicago, Illinois $75B AUM 11.27% 1-Year Est. Return

Nuveen's ELV Position: Q1 2026 in Review

Nuveen reduced its Elevance Health (ELV) stake by 0.74% in Q1 2026, selling an estimated $4.8M and leaving 1,960,705 shares worth $574M. The position accounts for 0.16% of the portfolio, ranked #115.

Nuveen first reported a position in ELV in Q2 2013 and has held it in 52 quarters since. The position peaked at $1.61B in Q4 2022. 1,466 funds tracked by Wall St. Rank hold ELV as of Q1 2026.

Nuveen held 1,960,705 shares of Elevance Health worth $574M as of Q1 2026.
Nuveen sold 14,612 Elevance Health shares in Q1 2026, an estimated $4.8M.
Elevance Health made up 0.16% of Nuveen's portfolio in Q1 2026, its #115 holding.
Nuveen first reported a position in Elevance Health in Q2 2013 and has held it in 52 quarters since.
Nuveen's Elevance Health position peaked at $1.61B in Q4 2022.
1,466 funds tracked by Wall St. Rank held Elevance Health as of Q1 2026.

Based on Nuveen's 13F filing for Q1 2026, filed 30 Apr 2026.